HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
86.97
-1.37 (-1.55%)
At close: Jun 15, 2026, 4:00 PM EDT
87.39
+0.42 (0.48%)
After-hours: Jun 15, 2026, 6:08 PM EDT
HealthEquity Revenue
HealthEquity had revenue of $354.64M in the quarter ending April 30, 2026, with 7.19% growth. This brings the company's revenue in the last twelve months to $1.34B, up 7.58% year-over-year. In the fiscal year ending January 31, 2026, HealthEquity had annual revenue of $1.31B with 9.47% growth.
Revenue (ttm)
$1.34B
Revenue Growth
+7.58%
P/S Ratio
5.44
Revenue / Employee
$475,205
Employees
2,814
Market Cap
7.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | 1.31B | 113.66M | 9.47% |
| Jan 31, 2025 | 1.20B | 200.18M | 20.03% |
| Jan 31, 2024 | 999.59M | 137.84M | 16.00% |
| Jan 31, 2023 | 861.75M | 105.19M | 13.90% |
| Jan 31, 2022 | 756.56M | 22.99M | 3.13% |
| Jan 31, 2021 | 733.57M | 201.58M | 37.89% |
| Jan 31, 2020 | 531.99M | 244.75M | 85.21% |
| Jan 31, 2019 | 287.24M | 57.72M | 25.15% |
| Jan 31, 2018 | 229.53M | 51.16M | 28.68% |
| Jan 31, 2017 | 178.37M | 51.58M | 40.69% |
| Jan 31, 2016 | 126.79M | 38.93M | 44.31% |
| Jan 31, 2015 | 87.86M | 25.84M | 41.67% |
| Jan 31, 2014 | 62.02M | 15.93M | 34.56% |
| Jan 31, 2013 | 46.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 13.65B |
| Veeva Systems | 3.32B |
| Teladoc Health | 2.51B |
| Privia Health Group | 2.25B |
| Tempus AI | 1.36B |
| Omnicell | 1.23B |
| Waystar Holding | 1.16B |
| Hinge Health | 646.34M |
HQY News
- 7 days ago - One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds - GlobeNewsWire
- 14 days ago - HealthEquity price target raised to $111 from $110 at Citizens - TheFly
- 17 days ago - HealthEquity price target raised to $108 from $100 at RBC Capital - TheFly
- 17 days ago - HealthEquity price target raised to $125 from $115 at BofA - TheFly
- 18 days ago - HealthEquity reports Q1 EPS $1.24, consensus $1.11 - TheFly
- 18 days ago - HealthEquity raises FY27 EPS view to $4.66-$4.73 from $4.56-$4.65 - TheFly
- 18 days ago - HealthEquity announces additional $1B of common stock repurchases - TheFly
- 18 days ago - HealthEquity Earnings Call Transcript: Q1 2027 - Transcripts